QualityStocks
  The QualityStocks Daily Newsletter for Tuesday, July 20th, 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters

1.

Stock Source (LKMG)

2.

Standout Stocks (HRRN)

3.

Bloomfield Investment Club (STHG)


The QualityStocks Daily

This week we received a call from the brother of one of our dear writers to tell us that Alex had passed away. Alex started out in “new product introduction”, but ended up writing for business publications such as Frost and Sullivan and Reed Elsevier. In some way, business analysis, forecasting, and trend analysis (and then writing about it) was second nature to him. He was an excellent writer for QualityStocks, always looking for new businesses and products with strong profit potential. We will miss him greatly and our prayers go out to his family and close friends.

Glen Rose Petroleum Corporation (GLRP)

Microcap Voice and SmallCap Voice reported previously on Glen Rose Petroleum Corporation (GLRP), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, Glen Rose Petroleum Corporation, formerly United Heritage Corporation focuses on the development of on-shore U.S. oil and gas assets. Glen Rose has four leases covering 10,500 acres in the Wardlaw Field located in Edwards County, Texas. The oil has categorization as "medium crude"; the deposits are in the light gravity range of heavy oil at 18-22 API gravity. Founded in 1981, Glen Rose Petroleum Corporation has their headquarters in Katy, Texas.

Glen Rose owns UHC Petroleum Corporation, a Texas corporation, which is a licensed operator with the Texas Railroad Commission. UHC Petroleum Corporation is an independent producer of natural gas and crude oil based in Dallas, Texas and Edwards County, Texas. UHC Petroleum operates the Wardlaw Field.

The Company's Management Team believes the acreage has always held great reserves, with the only question outstanding on the technology to extract the reserves properly. The Wardlaw Field is 10,502.3 acres (of which more than 10,000 acres are undeveloped) with production from the upper Glen Rose dolomitic deposit (A Zone) at a depth of approximately 300 feet. In total 142 wells have undergone drilling, and 92 are capable of production and of those 50 are active.

The Management Team completed an initial engineering study that indicates the field only requires the addition of pressure in order to establish meaningful long-term production. The owning of the area is under four full mineral leases (UHC 100 percent working interest) with a 25 percent Royalty. The leases have been perpetuated by drilling to-date to 2014. The Leases are all extended by 90 days for every well drilled on any part of the lease area, whether producing or not. The area leased also has deep gas potential from the Pennsylvanian/Atocka formations at 9,600 feet.

On March 5, 2010, Glen Rose Petroleum Corporation announced that they closed on a funding totaling $4,350,000 from Iroquois Capital Opportunity Fund, LP. The transaction consists of $3,350,000 in secured convertible notes and warrants, and $1,000,000 for the purchase of an undivided 12.5 percent working interest in the non-producing portions of their leases in the Wardlaw Field in Edwards County, Texas. Glen Rose Petroleum retained Nomad Energy, Inc. and Iromad LLC to advise and support field service and development at the Wardlaw Field with access to state of the art enhanced oil recovery technologies.

Glen Rose Petroleum Corporation (GLRP) closed Tuesday's trading at $0.35, up 40.00%, on 4,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 8,299 with a 52-week low/high of $0.20/$0.42.

FUQI International, Inc. (FUQI)

Penny Sleuth reported yesterday on FUQI International, Inc. (FUQI), Penny Invest, China Vesting did last week. Earlier, The Street, Market Wrap Daily, The Best Newsletters, Investment House, Greenbackers, Zacks.com, The Stock Advisors, Today's Financial News, Momentum Trades, Hit and Run Candle Sticks, Breakout Investments, and SmallCapInvestor.com reported on the Company, and we do as well, here at the QualityStocks Daily Newsletter.

FUQI International, Inc. is a leading designer, producer and seller of high quality precious metal jewelry in China. The Company develops, promotes, manufactures and sells a wide variety of products consisting of unique styles and designs made from gold and other precious metals such as platinum and Karat gold. Shenzhen Fuqi Jewelry Co., Ltd. (Shenzhen Fuqi) is a subsidiary of Fuqi International, Inc. Founded in 2001, and headquartered in Shenzhen, China, FUQI International, Inc. trades on the NASDAQ Global Select Market.

The Company offers basic gold jewelry, as well as an assortment of products. These include rings, bracelets, necklaces, earrings, and pendants made from precious metals, such as platinum, gold, palladium, and karat gold. FUQI International also manufactures jewelry with diamond and other precious stone inlays, as well as gold coins and gold bars.

The Company sells their products mainly to national and provincial distributors. They serve customers through approximately 31 provincial distributors and 840 direct sales agents in China. These provincial distributors sell the Company's products to local distributors, more than 900 retail outlets, and directly to end users in China. FUQI is also expanding into new markets and regions.

Each month, FUQI adds approximately 300 new designs to their extensive collection. The Company has a highly experienced management team with an extensive understanding of the jewelry business. In addition, they have a strong in-house design team, a highly skilled labor force and a modern production facility. They are a leading jewelry company with mass production capability, and a 53,000 square foot factory.

The Company has joined the Chinese Precious Jade Stone Association, Shanghai Gold Exchange Member, Guangdong Province Jade Jewelry Profession Association, Shenzhen Gold Jewelry Profession Association, International Platinum Gold Association and the World Gold Association Assigns Producer. They have also joined the China Association of Quality Inspection, Guangdong Province Association of Quality Inspection, and Shenzhen Inspection Association (level three member).

FUQI International, Inc. (FUQI) closed Tuesday's trading session at $7.87, up 12.11%, on 1,126,491 volume with 5,259 trades. The stock’s average daily volume over the past 60 days is 586,800 with a 52-week low/high of $5.90/$32.68.

Strategic Hotels & Resorts, Inc. (BEE)

DrStockPick.com, Otcstockexchange.com, and OTC Picks reported previously on Strategic Hotels & Resorts, Inc. (BEE), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Strategic Hotels & Resorts, Inc. is an industry-leading owner and asset manager of high-end hotels and resorts. They are a real estate investment trust (REIT) and the Company trades on the New York Stock Exchange (NYSE). As a REIT, they would not be subject to the federal income tax if they distribute 100 percent of their annual taxable income to their shareholders. Strategic Hotels & Resorts, Inc. has their corporate headquarters in Chicago, Illinois. 

The Company owns a portfolio of upper upscale and luxury hotels and resorts. These are in desirable North American and European locations. Their portfolio currently consists of 17 properties totaling 8,002 rooms. Strategic Hotels & Resorts, Inc. owns unique hotels with complex operations and multiple revenue streams. These hotels target the sophisticated customer niche.

Their properties are geographically diverse. They include large convention hotels, business hotels, and resorts. Internationally known hotel management companies are responsible for management of these properties. The Company's portfolio includes the Fairmont Chicago, the Four Seasons Hotel Washington, DC, the Intercontinental Miami, the London Marriott Grosvenor Square, the Ritz-Carlton Laguna Niguel, The Westin St. Francis, and more.

Strategic Hotels & Resorts, Inc.'s asset management expertise is their strength. Asset management is the Company's focus, their core competency, and what they believe is their competitive advantage. The Company's goal is to use their experience and strong balance sheet to make selective, value added acquisitions and recycle capital through thoughtful and planned dispositions.

On July 8, 2010, Strategic Hotels & Resorts, Inc. announced that they would report financial results for the second quarter 2010 after the close of business on August 4, 2010. The Company has scheduled a quarterly conference call for investors and other interested parties for 10:00 a.m. ET on Thursday, August 5, 2010. Management will discuss the Company's second quarter 2010 results. A taped rebroadcast will be available beginning at 1:00 p.m. ET on August 5, 2010, through 11:59 p.m. ET on August 12, 2010.

Strategic Hotels & Resorts, Inc. (BEE) closed today's session at $3.93, up 2.08%, on 3,369,505 volume with 14,829 trades. The stock’s average daily volume over the past 60 days is 4,914,305 with a 52-week low/high of $0.98/$6.97.

Sangamo BioSciences Inc. (SGMO)

The Street, The Stock Advisors, and Today's Financial News reported earlier on Sangamo BioSciences Inc. (SGMO), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Sangamo BioSciences, Inc. focuses on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The Company has established strategic partnerships with companies in non-therapeutic applications of their technology including Dow AgroSciences and Sigma-Aldrich Corporation. Sangamo BioSciences Inc. has their corporate headquarters in Richmond, California. They trade on the NASDAQ Global Market.

The Company's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function.  Sangamo is also developing sequence-specific ZFP Nucleases (ZFNs) for gene modification. 

The most advanced ZFP Therapeutic™ development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has two Phase 1 clinical trials to evaluate safety and clinical effect of a treatment for HIV/AIDS and another Phase 1 trial to evaluate safety and clinical effect of a treatment for recurrent glioblastoma multiforme. Other therapeutic development programs focus on neuropathic pain, nerve regeneration, Parkinson's disease, and monogenic diseases.

In their program for HIV/AIDS, which is in a Phase 1 clinical trial at the University of Pennsylvania, they are using ZFNs to disrupt CCR5, a co-receptor for HIV. The Company's goal is to generate a protected population of immune system cells that cannot be infected by the virus and are available to fight opportunistic infections and the virus itself.

On July 6, 2010, Sangamo BioSciences, Inc. announced the publication of data demonstrating the preclinical efficacy of a human stem cell therapy for human immunodeficiency virus (HIV) based on their proprietary zinc finger DNA-binding protein nuclease (ZFN) technology. The ZFN approach enables the permanent disruption of the CCR5 gene, which encodes an important receptor for HIV infection, in all the cell types comprising the immune system that develop from hematopoietic stem cells (HSCs). The ZFN approach is the basis for a promising therapeutic strategy for the treatment of HIV/AIDS. Sangamo has two ongoing Phase 1 clinical trials to evaluate the safety and clinical efficacy of this approach in CD4+ T-cells.

Sangamo BioSciences Inc. (SGMO) closed Tuesday's session at $4.18, up 12.67%, on 380,245 volume with 1,525 trades. The stock’s average daily volume over the past 60 days is 262,784 with a 52-week low/high of $3.26/$9.39.

NICE Systems Ltd. (NICE)

Today we are highlighting NICE Systems Ltd. (NICE), here at the QualityStocks Daily Newsletter.

Trading on the NASDAQ Global Select Market, NICE Systems Ltd. is the leading provider of Insight from Interactions solutions and value-added services, powered by advanced analytics of unstructured multimedia content – from telephony, web, radio and video communications. The Company's solutions address the needs of the enterprise and security markets. This enables organizations to operate in an insightful and proactive manner, and take immediate action to improve business and operational performance and ensure safety and security. NICE Systems Ltd. has their International Corporate Headquarters in Ra'anana, Israel and their Americas office in Rutherford, New Jersey.

The Company's solutions find use by enterprises from a variety of industries. These include financial services, telecommunications, healthcare, outsourcers, retail, service providers, and utilities. NICE's security solutions mainly focus on city center protection working with first responders and homeland security entities, transportation organizations, and the public and private sectors. NICE has over 24,000 customers in more than 150 countries, including over 85 of the Fortune 100 companies.

NICE's comprehensive business solution offering consists of NICE SmartCenter. This includes call recording, quality management, interaction analytics, performance management, workforce management, a customer feedback application, and agent coaching. They also offer, through Actimize, a NICE company, software solutions for anti-money laundering, brokerage compliance and fraud prevention built on a patented, scalable, and extensible analytics platform.

NICE provides advanced solutions for homeland security and first responders, transportation, government and the private sector. Their next generation security solutions empower security personnel to detect, prevent, and respond to threats in real-time. Their solutions also empower them to investigate and reconstruct criminal and security cases using video surveillance and control services, incident monitoring, and reconstruction solutions.

NICE solutions provide a complete, unified, chronological, multimedia history of incidents. These solutions implement real-time video analytics, IP networking, recording and management for automatic threat detection, instant verification, event resolution and effective investigation.

Yesterday, KeyCorp (NYSE:KEY) announced that they signed an agreement with NICE Actimize, a NICE Systems company. This is to strengthen further their ability to proactively detect and mitigate consumer and commercial fraud. NICE Actimize is a leading provider of financial crime, risk and compliance solutions.

"We are happy to be working with Key to help them continue to proactively manage fraud threats," said Amir Orad, CEO of NICE Actimize. "Key is joining the NICE Actimize community of leading global firms who use our cross-channel financial crime prevention solutions to improve the customer experience by better managing transactional risks for both retail and commercial customers."

NICE Systems Ltd. (NICE) closed Tuesday's trading session at $26.00, up 0.15%, on 137,523 volume.

Imaging3 Inc. (IMGG)

OTC reporter, Cool Penny Stocks, HotOTC.com, Stock Rich, Microcap Voice, OTC Press, Hot Stock Chat, Penny Invest, Stock Traders Chat, StockEgg.com, and Stock Stars reported earlier on Imaging3 Inc. (IMGG) and we highlight the Company, here at the QualityStocks Daily Newsletter.

Imaging3 Inc. is a leading provider of advanced technology medical imaging devices. Founded in 1993 by Dean Janes, the Company has developed a breakthrough medical imaging device.  This device produces 3D medical diagnostic images of virtually any part of the human body in real-time. Imaging3 Inc. trades on the OTC Bulletin Board. They have their headquarters in Burbank, California.

The 3D images, instantly constructed in real-time, are useable for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Healthcare workers using Imaging3 devices will be able to view instantly 3D, high-resolution images. The Company intends to use their existing base of operations and channels of distribution to launch their new medical imaging devices business, based on this Imaging3 Technology.

The Dominion Volumetric Imaging Scanner (DVIS) is a patented mobile fluoroscopy technology. This product can produce a combination of mobility, high quality imagery, low radiation, low cost, 3D and real time, in the same device. A diagnostic medical imaging device built with Imaging3 technology can perform several functions and can replace or supplement several existing devices.

Functions that a device that has this technology can perform include performing real-time, three-dimensional medical imaging. They can also emulate a CT scanner, at a lower capital cost, as well as perform standard fluoroscopy. In addition, a device could cross over to other modalities such as digital radiography. The Imaging3 technology can help mitigate the costs of buying a CT scanner.

The DVIS is suited to increasing the speed and accuracy of diagnosis in a trauma environment. Having the ability to view immediately 3D images of a patient could be the difference in providing the correct diagnosis.

Imaging3 is also the largest remanufacturer of C-arms in the world. A C-arm is an integral component of a fluoroscopic imaging system used for various types of surgery. The Company offers new, demo, remanufactured, refurbished and pre-owned systems in all price ranges from every major manufacturer. Imaging3 supplies full-size, compact, and mini C- arms.

The Company is also the largest distributor of C-arm tables in the U.S. They offer new, demo, remanufactured, refurbished, and pre-owned C-arm tables in all price ranges from every major manufacturer. The Company also supplies pain management tables, surgery tables, urology tables, and vascular tables.

Today, Imaging3 Inc. (IMGG) closed at $0.25, up 9.22%, on 2,100,380 volume with 360 trades. The stock’s average daily volume over the past 60 days is 1,174,631 with a 52-week low/high of $0.029/$1.95.

Hovnanian Enterprises Inc. (HOV)

Last week, Stock Traders Chat reported on Hovnanian Enterprises Inc. (HOV), Market Wire Stocks, Investorplace, The Street, The Tycoon Report, Trading Markets, ChartAdvisor.com, Momentum Trades and Daily Profit did previously, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Hovnanian Enterprises, Inc. engages in homebuilding and financial services businesses in the United States. K. Hovnanian® Homes® is a nationally recognized homebuilder, founded in 1959 by Kevork S. Hovnanian. The Company is now in its second generation of family leadership. Hovnanian Enterprises Inc. trades on the New York Stock Exchange (NYSE). They have their headquarters in Red Bank, New Jersey.
 
Due to various acquisition efforts, K. Hovnanian® has expanded over the years to become a family of homebuilders. They have localized expertise in markets throughout the U.S.  K. Hovnanian® Homes® operates in Arizona, California, Delaware, Florida, Georgia, Illinois, Kentucky, Maryland, Minnesota, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Texas, Virginia and West Virginia.

Hovnanian designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, mid-rise and high-rise condominiums, urban infill, and active adult homes. The Company markets and builds homes for first-time buyers, first and second-time move-up buyers, luxury buyers, active adult buyers, and empty nesters. Hovnanian Enterprises, Inc. also provides an assortment of financial services. These include originating mortgages from homebuyers, and title insurance activities.

Hovnanian markets and sells their homes under the trade names K. Hovnanian® Homes®, Matzel & Mumford, Brighton Homes, Parkwood Builders, Town & Country Homes, Oster Homes and CraftBuilt Homes. As the developer of K. Hovnanian's®Four Seasons communities, the Company is also one of the nation's largest builders of active adult homes.

The design of K. Hovnanian's Metro Living communities is for urban homebuyers who appreciate an exciting metropolitan lifestyle and a big city attitude. They create these condominium homes, penthouses and studios for people who have an eye for design and a passion for elegant living. For those looking to build their own homes, the Company will manage all the details for those who don't want to handle the challenges and costs of trying to be their own home contractor.

On June 3, 2010, Hovnanian Enterprises, Inc. announced that they are a recipient of the 2010 CIO 100 by IDG's CIO Magazine. The 23rd annual award program recognizes organizations globally that exemplify the highest level of operational and strategic excellence in information technology (IT).  The 2010 CIO 100 awards will present at the Terranea Resort in Rancho Palos Verdes, California, on August 24, 2010 at the conclusion of the twelfth annual CIO 100 Symposium® and Awards Ceremony.

Hovnanian Enterprises Inc. (HOV) closed Tuesday's session at $4.04, up 5.21%, on 3,497,110 volume with 10,397 trades. The stock’s average daily volume over the past 60 days is 4,695,703 with a 52-week low/high of $2.50/$8.05.

Gold American Mining Corp. (SILA)

Today, Market Wrap Daily, Market FN, Investor Spec Sheet, Another Winning Trade, Investment House, The Stock Advisors, Trade of the Week, and Stock Research Newsletter reported on Gold American Mining Corp. (SILA), The Green Baron and Daily Profit did yesterday, and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Gold American Mining Corp. is a precious metal exploration company. Their focus is on the aggressive, ongoing acquisition and exploration of holdings with rich silver and gold production potential. They have developed a promising portfolio of international properties in regions marked by stable politics, sound economies, and friendly business relations. Gold American Mining Corp. has their headquarters in Reno, Nevada. Effective June 23, 2010, Silver America, Inc. changed their name to Gold American Mining Corp. to reflect better the nature and primary focus of the Company's business operations.

The Company's projects include the 240-acre Keeno Strike Property in Clark County, Nevada.  It is in the Goodsprings/Yellow Pine Mining District, and consists of the historical Monte Cristo mine and Keeno-Mint prospect. The goal of the exploratory work program will be to test approximately 1.1 million ounces of Au and approximately 69.0 million ounces of Ag potential. This would be accessible by open-pit bulk handling methods unavailable to the industry at the time these properties initially underwent development.

A reconnaissance report prepared in Quarter 2, 2008 determined that Gold American Mining Corp.'s holdings, which include the historical Monte Cristo mine and Keeno-Mint prospect, represent sufficient resources to justify the next phase of the property's exploration.  The property is about 30 miles southwest of Las Vegas.

In addition, Gold American Mining Corp.'s Guadalupe Property contains two historic mines. It is currently producing 3 to 4 tonnes of ore per day. It is in one of Mexico's oldest mining districts approximately five miles north of the Fresnillo (Proano) Mine, the world's richest underground silver mine operated by London-listed Fresnillo plc.

On July 14, 2010, Gold American Mining Corp. provided an update on the ongoing work program at the Company's Guadalupe Property in Zacatecas State, Mexico. The initial plan for the ongoing field program at the Guadalupe Property was to consist of 10.6 line miles (17 line kms) of magnetic and induced polarization surveys, as well as further detailed sampling and mapping of the entire Guadalupe area and workings. Upon review of preliminary results of the magnetic survey, a number of geophysical anomalies have undergone identification. Consequently, the Company has decided to increase the geophysics program to cover 13.7 line miles (22 line kilometers). They expect to have additional information on the program by the end of this month.

Gold American recently acquired additional historical geological data for the Guadalupe property and surrounding area. This data indicates that additional historical workings exist within the property that have not been visited or sampled by Gold American to date.

Gold American Mining Corp. (SILA) closed Tuesday's trading session at $0.85, up 11.84%, on 1,090,355 volume with 376 trades. The stock’s average daily volume over the past 60 days is 138,784 with a 52-week low/high of $0.002/$1.45.

The QualityStocks Company Corner

NetSol Technologies, Inc. (NTWK)

The QualityStocks Daily Newsletter would like to spotlight NetSol Technologies, Inc. (NTWK). Today, NetSol Technologies, Inc. closed trading at $0.8298, up 1.88%, on 129,764 volume with 206 trades. The stock’s average daily volume over the past 60 days is 182,720 with a 52-week low/high of $0.70/$1.31.

NetSol Technologies, Inc. (NTWK) announced that they signed a LeaseSoft license upgrade agreement with Singers Healthcare Finance Limited (SHFL), one of the UK's leading providers of leasing solutions to the healthcare industry.

NetSol Technologies, Inc. (NTWK) a worldwide provider of global business services and enterprise application solutions, leverages its BestShoring(TM) practices and highly experienced resources to deliver high-quality, cost-effective solutions. The ir suite of products and services include credit and finance portfolio management systems, hospital/healthcare information management systems (HIMS), SAP consulting and services, custom development, systems integration, and technical services.

NetSol’s commitment to quality is demonstrated by its achievement of the ISO 9001, ISO 27001, and SEI (Software Engineering Institute) CMMI (Capability Maturity Model) Maturity Level 5 assessments, a distinction shared by less than 100 companies worldwide. These distinctions are a result of adhering to rigorous quality standards, resulting in the delivery of solutions that are secure, reliable, properly planned, and meticulously executed.

Serving the global financial, healthcare, insurance, energy, and technology markets, NetSol has operations, offices, and joint ventures in Adelaide, Bangkok, Beijing, Lahore, London, Riyadh, San Francisco, and San Pedro Sula. NetSol Technologies' clients include Fortune 500 manufacturers, global automakers, financial institutions, utilities, technology providers, and government agencies.

NetSol Technologies, Inc. (NTWK), is well positioned with its core product offerings as it continues to expand into new international market opportunities. Looking forward, the company is very optimistic of its short-term and long-term outlook as it sees strong growth in Asia Pacific as well as the South East Asian markets, while also envisioning unlimited potential for its niche solutions and services in the Americas. Disclaimer

NetSol Technologies, Inc. Blog

NetSol Technologies, Inc. News:

NetSol Technologies Europe Signs LeaseSoft Upgrade Agreement With Singers Healthcare Finance Limited

CRWE Wallstreet Announces Stock Watch on SSHO, ENOC, ASTM, NTWK

NetSol North America Sales Rebound After Stream of New Orders From Existing Clients

Simulated Environment Concepts, Inc. (SMEV)

The QualityStocks Daily Newsletter would like to spotlight Simulated Environment Concepts, Inc. (SMEV). Today, Simulated Environment Concepts, Inc. closed trading at $0.0114, down 3.39%, on 47,900 volume with 9 trades. The stock’s average daily volume over the past 60 days is 134,608 with a 52-week low/high of $0.001/$0.07.

Simulated Environment Concepts announced that they have contracted with the United Arab Emirates company I. SEPTA Co., LTD., to secure a multi-million dollar deal to manufacture over 150 SpaCapsules for the Middle Eastern Region.

Simulated Environment Concepts, Inc. (SMEV) is focused on manufacturing and distributing their patented SpaCapsule® as well as continued innovation in the areas of anti-aging, cosmetics, relaxation, cellulite reduction, and weight loss. Finding use in numerous environments such as relaxation centers, golf clubs, ski lounges, gyms, and health clubs, the SpaCapsule® provides next generation de-stressing and relaxation.

The company’s founders, Dr. Ella Frenkel and Dr. Ilya Spivak, initially capitalized Simulated Environment Concepts Inc. with several million dollars of their own money. With this initial investment, the company worked on, and succeeded in developing, the sleek and stylish looking pressurized dry water massage relaxation station.

SpaCapsule® is a full body massage, aromatherapy, audio and video entertainment system. The capsules are fused with advanced modern technology and healing methods of aromatherapy and audiovisual relaxation techniques, incorporating proprietary water-jet and pressure-jet technology that requires no on-site plumbing. Weighing approximately 500 lbs, the capsule only requires standard electric service.

Simulated Environment Concepts, Inc. (SMEV) anticipates progressive and consistent growth over the next six years. With individuals spending billions of dollars on de-stressing, weight loss, anti aging, cosmetics, massage and physical rehabilitations, the company is in a position to experience explosive growth from current levels. Disclaimer

Simulated Environment Concepts, Inc. Blog

Simulated Environment Concepts, Inc. News:

Simulated Environment Concepts Continues Global Expansion With Another Multi-Million Dollar International Production Deal by Way of United Arab Emirates' Distributor

Dermscan's Research to Support SpaCapsule's Weight Loss/Anti-Cellulite Benefits

Simulated Environment Concepts Receives Additional Operation Capital

Micro Identification Technologies Inc. (MMTC)

The QualityStocks Daily Newsletter would like to spotlight Micro Identification Technologies Inc. (MMTC) Today Micro Identification Technologies Inc. closed trading at $0.0250, up 8.23%, on 226,900 volume with 10 trades. The stock’s average daily volume over the past 60 days is 317,490 with a 52-week low/high of $0.02/$0.155.

Micro Identification Technologies Inc. (MMTC) is focused on becoming a global leader in developing, supporting and marketing rapid systems and processes that detect and identify microbial organisms. For several years the company has been working on the development of a breakthrough, laser-based microbial identification technology. This technology has been designed to be extremely fast and easy to use while not relying on conventional chemical or biological processing, fluorescent tags, gas chromatography or DNA analysis.

The system works by measuring scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. By measuring scattered light at specific angles, MIT’s system detects and differentiates objects the size of bacteria, protozoa, yeasts and molds.

The company’s technology offers significant advantages over today’s methods of microbial detection, including lower cost, rapid results, easier use and the ability to test for multiple bacteria in one process. The system is statistically based and includes a unique MIT Microbe Library of pre-measured light scattering identifiers - or fingerprints - derived from the measurements of tens of thousands of individual microbes for each species and subspecies to be detected.

MIT’s technology has the potential to revolutionize the $5 billion rapid microbial test market by annually saving thousands of lives and tens of millions of dollars. Since 1998, the industry has had an annual expansion of 9.2 percent - with growth projections for 30 percent annually. MIT is well positioned with its cutting-edge microbial technology as demand continues to soar as a result of major health, safety and homeland security issues. Disclaimer

Micro Identification Technologies Inc. Blog

Micro Identification Technologies Inc. News:

MIT Initiates Expansion Plans Enabled by Recently Completed Manufacturing and Financing Agreements

MIT Contracts OSI Optoelectronics to Manufacture the MIT 1000 Rapid Microbial Identification System

U.S. Equity News Features Micro Identification Technologies in the Fight Against Bacteria

Uranium Energy Corp. (UEC)

The QualityStocks Daily Newsletter would like to spotlight Uranium Energy Corp. (UEC) Today, Uranium Energy Corp. closed trading at $2.28, up 5.07%, on 349,092 volume with 1,049 trades. The stock’s average daily volume over the past 60 days is 367,964 with a 52-week low/high of $2.10/$4.16.

Uranium Energy Corp. (UEC) is a U.S.-based exploration and development company focused on near-term uranium production in the U.S. The company’s operations are managed by professionals who have earned a reputable profile through many decades of hands-on experience in the key facets of uranium exploration, development and mining.

Uranium Energy controls one of the largest databases of historic uranium exploration and development in the nation. Using this knowledge base, the company has acquired and is advancing exploration properties of merit throughout the southwestern U.S., a region known as being the most concentrated area for uranium mining in the United States.

The Company’s fully licensed and permitted Hobson processing facility is central to all of its projects in South Texas. Well financed to execute on its key programs, Uranium Energy's Palangana is-situ recovery project is fully permitted, and its Goliad in-situ recovery project is in the final stages of mine permitting for production.

The company’s strategy of acquiring exploration databases and leveraging those databases to generate acquisition targets has proven to be effective thus far. With plans to continue aggressively pursuing this strategy, Uranium Energy Corp is well positioned to capitalize on the world’s first significant alternative energy boom. Disclaimer

Uranium Energy Corp. Blog

Uranium Energy Corp. News:

Uranium Energy Corp Announces Historical Resource of 1.5 Million Pounds eU3O8 at the Company's Salvo Project in South Texas

BUYINS.NET Updates Uranium Energy Corp SqueezeTrigger Report

Uranium Energy Corp Discovers New Exploration Zone and Reports Strong Drill Results at Palangana in South Texas

Cellceutix Corp. (CTIX) Offers Hope to Cancer Industry and Opportunity to Investment Community

Lung cancer is still the number one cause of cancer death among men and women in the United States. Projections for 2010 by the American Cancer Society include over 220,000 new cases of lung and bronchial cancers with nearly 160,000 deaths as a result of lung cancer. If projections hold true, the number of new cases will be greater than the 173,770 cases that were reported in 2004. Another interesting fact is that, while leveling in the last several years, the number of deaths among women attributed to lung cancer has not seen a significant decline with the other major lines of cancer since 1990. Projections for 2010 have the number of deaths in women from lung cancer being approximately 10% greater than breast, colon and rectum cancers combined.

Lung carcinomas have proven to be very resilient with a great ability to adapt to chemotherapy treatments and still present a great area of need for new therapies. Multi-drug resistance, the principal mechanism by which many carcinoma strains develop resistance to chemotherapy drugs, is one of the primary reasons for ineffectiveness of standard cancer therapies on the market today. Cellceutix Corporation (CTIX.OB) trades on the NASDAQ Bulletin Board in the area of $.60 per share and is making significant strides with Kevetrin, their lead compound in development for treatment of multi-drug resistant cancer strains of the lung, breast and colon. Cellceutix is compiling the final data from pre-clinical toxicology studies to file an Investigational New Drug (IND) application with the USFDA in preparation for human trials of Kevetrin. Cellceutix plans to ask for the application to be “fast tracked” to expedite the procedure.

Cellceutix has developed and researched Kevetrin from the ground up with very promising results in pre-clinical studies. The latest pharmacology studies were released last week with the data coinciding with all other previous research. Kevetrin has already received accolades from posters being presented by Cellceutix at the American Association for Cancer Research (AACR). The AACR is considered by most to be the leading institute for cancer research in the world today. A poster on Kevetrin was highlighted at the AACR’s “Frontiers in Basic Cancer Research Meeting” in Philadelphia in October 2009. Research on Kevetrin has demonstrated success in more than 5,000 small animal tests, achieving significant delays in tumor growth compared to controls in multi-drug resistant lung, breast and colon cancer cell lines. The data also showed that a second cycle of Kevetrin continued to delay tumor growth without any development of resistance.

From an investment standpoint, Cellceutix has a very low market cap of around $40 million. There is a large insider holding ratio (approximately 50%) and a low float of approximately 40 million shares available for free trading. The Cellceutix management has been primarily funding operations independently without dilution of the share structure. It is apparent that they feel strongly their company’s compounds can reap great rewards in the future.

Leo Ehrlich, Chief Financial Officer of Cellceutix, stated, “When talking about a successful approved drug for resistant cancers, you must realize that you are talking about revenue possibilities into the billions of dollars. Presently, this is one of the most sought areas of drug development or acquisition by big pharma. ”

Mr. Ehrlich said, “Just over the last month we were contacted and invited by a major pharmaceutical company and a major financial institution interested in learning more about Cellceutix. Nothing is ever a complete certainty, but we anticipate continued success and the true value of our company to continue to be realized.”

The CTIX price per share has been steadily increasing this year with a 2010 low of $.20 and presently trading at $.66. To learn more about Cellceutix, Kevetrin and the investment opportunity Cellceutix presents, please visit the Cellceutix website at www.cellceutix.com.

Simulated Environment Concepts, Inc. (SMEV) Continues to Expand Internationally with Additional Multi-Million Dollar International Production Deal

Simulated Environment Concepts, makers of the high pressurized dry water massage and relaxation station SpaCapsule, announced today that it has contracted with the United Arab Emirates company I. SEPTA Co., LTD., to secure a multi-million dollar deal to manufacture more than 150 SpaCapsules for the Middle Eastern Region.

“This is a significant milestone,” commented Dr. Ilya Spivak, Marketing Director of Simulated Environment Concepts (SE Concepts). “The global Muslim population is approximately 1.82 billion individuals. Considering the strict modesty rules preventing cross-gender massage, this deal opens the door to our SpaCapsules being used by the Islamic community throughout the world, positioning our company for continuous expansion, viability and use.”

When the company signed its December 2009 manufacturing deal with French company Zen & O to produce 250 SpaCapsules, it was evidence of the personal wellness industry thriving in Europe. Although the deal announced this morning is similar, it appeals to yet another and perhaps more significant concept, modesty. As the SpaCapsule’s technology caters to the fully dressed individual, both Muslim men and women can now enjoy healthful massage-therapy sessions, with all of the benefits of cellulite reduction, weight loss, relaxation, etc., without any concerns of indecency.

“We are delighted to partner with a progressive and forward-looking company like SE Concepts,” stated Mr. Hamid Ghods, Director of I. SEPTA, Co., LTD. “We have run an analysis on the use and acceptability of the SpaCapsule concept and we have learned that it should be a viable and well used product in our gyms, health clinics, spas, and hotels. We have already sold the first seven units, eagerly anticipate their arrival and expect to make additional orders in short order.”

Dr. Ella Frenkel, Chairman and CEO of Simulated Environment Concepts, Inc., added, “This manufacture and distribution agreement continues to expand our reach into the Middle East. It is a true compliment to our previous arrangements with Jordan and Egypt and will likely increase acceptance and sales throughout the region.”

According to the press release today, the arrangement calls for production and distribution between the two companies to continue over the next four years with an average of 38 SpaCapsules ordered annually. Those close to the company suggest, like the French distribution deal, there is a possibility the UAE arrangement will be accelerated, potentially fulfilling the current contract closer to two years and significantly increasing SE Concepts’ short-term revenues.

NetSol Technologies, Inc. (NTWK) Announces Upgrade Agreement with Singers Healthcare Finance Limited

NetSol Technologies, Inc., a worldwide provider of global IT and enterprise application solutions, this morning announced that the Company has signed a LeaseSoft license upgrade agreement with Singers Healthcare Finance Limited (“SHFL”), one of the UK’s leading providers of leasing solutions to the healthcare industry.

As terms of the agreement, SHFL will upgrade to the latest version of NetSol’s LeaseSoft asset management solution. With this upgrade, SHFL will gain a large number of functionality enhancements, including specific enhancements to support SHFL’s expanding business within the healthcare equipment leasing industry.

Susan Hinton-Smith, CEO of SHFL, commented, “We have enjoyed a successful relationship with NetSol, and this upgrade agreement is made in the certain knowledge that NetSol delivers on its promises. During our time working with NetSol, we have always found them to be refreshingly open and honest. Their consultants thoroughly understand our business, and the Company’s approach has always been flexible and commercially realistic. We view NetSol as a partner, and we look forward to extending that partnership in the years ahead.”

Naeem Ghauri, CEO and Head of Global Sales for NetSol Technologies Europe, stated, “We are delighted that SHFL has decided to work with us for their system upgrade project. We are immensely proud of our customer base and the longstanding relationships we develop. SHFL’s decision is proof that, as a business, we are in tune with our customers, have deep domain expertise and provide a strong solution, service and support package. It is gratifying to win a new customer, but equally as important to know that our existing customers are happy to come back for more.”

Access Pharmaceuticals, Inc. (ACCP) Signs Major Distribution Agreement with BioScrip

Access Pharmaceuticals, a biopharmaceutical company specializing in products for cancer and supportive care, announced today the signing of an agreement with BioScrip (NASDAQ: BIOS) for the distribution of MuGard, the lead product of Access. MuGard is an FDA approved oral wound rinse for the management of oral mucositis, a debilitating side effect of radiotherapy and/or chemotherapy. The agreement provides for the distribution of MuGuard through BioScrip’s nationwide distribution platform, including 110 BioScrip specialty pharmacies. It also allows Access to leverage BioScrip’s extensive physician relationships, and provides for mail distribution and a diversified payor network.

BioScrip is a national provider of specialty pharmacy and home care products and services, working with patients, physicians, hospitals, healthcare payors, and pharmaceutical manufacturers. Access VP of Sales and Marketing, Frank Jacobucci, spoke of the significance of the BioScrip agreement. “As one of the largest, top-tier players in this space, BioScrip is well-established, reputable and focused on tailoring its programs to best fit and meet product manufacturers, provider and payers and patients’ pharmacy service needs. In addition to the varied services that they will provide us, this partnership also results in multiple delivery options for patients in need of MuGard, including overnight delivery, home delivery and live retail pharmacy sites in the top metropolitan areas. We believe offering various methods of receiving MuGard can significantly increase patient compliance and ultimately provide an important additional weapon to help improve the treatment outcome.”

Access CEO, Jeffrey Davis, said, “Signing a strong specialty distribution partner is a critical milestone for a successful entrance into the US market. With its significant resources, deep capabilities and strong commitment to cancer patients, BioScrip is an ideal partner to have in place as we continue executing on our global-commercialization strategy for MuGard.”

BioScrip VP of Trade Relations and Business Development, Scott Friedman, said, “BioScrip is proud to have been selected by Access to be its exclusive distribution and service partner for MuGard. Our vast clinical, sales and operational specialty pharmacy assets, combined with our deep oncology experience, put us in a unique position to provide services to the patient, manufacturer, provider and payor communities.”

 


Sponsors of the Day

 

The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) MIT Initiates Expansion Plans Enabled by Recently Completed Manufacturing and Financing Agreements

QualityStocks

We’re sorry, but the newsletter database and chart is currently unavailable. Our data analysts are actively working to resolve the issue.

 

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336